Cellosaurus KTC1res.1 (CVCL_A2CS)
| Cell line name | KTC1res.1 |
|---|---|
| Synonyms | KTC1res_1; Res.1 KTC1 |
| Accession | CVCL_A2CS |
| Resource Identification Initiative | To cite this cell line use: KTC1res.1 (RRID:CVCL_A2CS) |
| Comments | Population: Japanese. Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032). Omics: Genomics; Whole exome sequencing. Omics: Variations; Array-based CGH. Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
| Sequence variations |
|
| Disease | Poorly differentiated thyroid gland carcinoma (NCIt: C6040) Thyroid carcinoma (ORDO: Orphanet_100088) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_6300 (KTC-1) |
| Sex of cell | Male |
| Age at sampling | 68Y |
| Category | Cancer cell line |
| Publications | PubMed=29156680; DOI=10.18632/oncotarget.21262; PMCID=PMC5689570 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_A2CS |
| Encyclopedic resources | Wikidata; Q105509839 |
| Polymorphism and mutation databases | Cosmic; 2755723 |
| Entry history | |
| Entry creation | 12-Jan-2021 |
| Last entry update | 10-Apr-2025 |
| Version number | 8 |